CompoAtlas

Marmorek

Natural health product licensed in Canada

Licence holder
Laboratoire Schmidt-Nagel Inc.
NPN or DIN-HM
80051086
Status
Active licence
Licence date
23 May 2014
Revision date
3 December 2015
Form
Granules
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Lactose, Saccharose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years5 granule3 days
Adolescentesminimum: 13 years ; maximum: 17 years5 granule3 days

Uses authorised in Canada

Remède de nosodes.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80051086

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2015. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2015. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line